Mochi Health vs Henry Meds

Both sell tirzepatide. Mochi Health costs $278 a month and Henry Meds costs $449, a difference of $171 a month or about $2,052 a year. The other differences matter more than the money if this is your first course.

Mochi Health is insurance concierge support. Henry Meds is sublingual and oral formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.

What this means for your titration. Mochi Health holds one price at every dose and Henry Meds does not — so this gap widens as you titrate toward a therapeutic dose, exactly when you can least afford a surprise.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The differences that affect treatment

They differ on 4 of the 7 things we track, and behave the same on the other 3. The differences are what the price gap is actually buying.

What each programme publishes: Mochi Health

• Membership $79/month, or about $66/month on longer prepaid terms.
• Prepaid terms listed at $199 for three months, $399 for six and $799 for twelve.
• Compounded semaglutide around $99 and tirzepatide around $199 on published dose ranges.
• Some members report $69/month provider access with $175 per 28 days of compounded semaglutide.
• Holds roughly a 4 to 4.5 star Trustpilot average across approximately 18,000 public reviews.
• Lab work, where recommended, is not included in the membership.

Where it wins: The insurance concierge genuinely pursues coverage rather than defaulting to cash pay. Watch for: Labs are billed separately. Ask what the clinic expects to order before you sign up.

What each programme publishes: Henry Meds

• Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
• Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
• Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
• Three-month oral tirzepatide supply $1,047, or $891 paid in full.
• Three-month oral semaglutide supply $747, or $537 paid in full.
• Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

Where it wins: No membership fee layered on top of medication. Watch for: The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

Strengths of each

Mochi Health.

• The insurance concierge genuinely pursues coverage rather than defaulting to cash pay.
• Large, public review base rather than a handful of curated quotes.
• Prepaid terms meaningfully reduce the membership cost.

Henry Meds.

• No membership fee layered on top of medication.
• Real choice of sublingual, oral tablet and injection.
• Discounts for paying a multi-month block up front.

How they score

Mochi Health scores higher overall at 3.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

Which suits you

• Pick Mochi Health if cost is the binding constraint. Over a year the gap is about $2,052, which is real money for the same class of medication.
• Pick Henry Meds if what it does better matters to you — no membership fee layered on top of medication.
• Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.

The verdict

For most people starting out, Mochi Health at $278 a month is the more defensible choice on arithmetic alone. Henry Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Mochi Health and Henry Meds.

How they sit against everyone else